ANAB Stock Analysis: Buy, Sell, or Hold?
ANAB - AnaptysBio, Inc. Common Stock
$59.43
-0.56 (-0.93%)
▼
5d:
-0.13%
30d:
-1.62%
90d:
-5.25%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When ANAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ANAB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$81.43
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$50.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANAB is currently trading at $59.43, which is considered slightly high relative to its 30-day fair value range of $52.71 to $59.90. The stock's valuation (Forward PE: 11.3) is in line with its historical norms (11.1). At these levels, the market is pricing in 0.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ANAB is in a uptrend. Immediate support is located at $50.59, while resistance sits at $62.32.
Market Sentiment: ANAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $87.09 (+46.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANAB is in a uptrend. Immediate support is located at $50.59, while resistance sits at $62.32.
Market Sentiment: ANAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $87.09 (+46.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$52.71 -
$59.90
Company Quality Score
58/100
(HOLD)
Options IV Signal
43th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- NEUTRAL: Options fairly priced (IV 43th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.5% below Wall St target ($87.09)
- NEUTRAL: Market pricing in 0.8% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$52.71 -
$59.90
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$7.09
(11.9%)
Support & Resistance Levels
Support Level
$50.59
Resistance Level
$62.32
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.35
Wall Street Target
$87.09
(+46.5%)
Revenue Growth (YoY)
-8.0%
Profit Margin
-11.5%
Valuation Premium vs History
+0.8% premium
PE vs Historical
11.4 vs 11.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.8%
(market-implied from PE analysis)
1-Year Target
$59.91
(+1%)
2-Year Target
$60.38
(+2%)
3-Year Target
$60.87
(+2%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
PE COMPRESSION
$59.52
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 23, 2026 6:30 PM ET
Data refreshes hourly during market hours. Next update: 7:30 PM
Data refreshes hourly during market hours. Next update: 7:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
John P Schmid
SELL
20645 shares
2026-03-30
Daniel Faga
SELL
17679 shares
2026-03-27
Eric J Loumeau
SELL
10000 shares
2026-02-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 59 HOLD |